- Pharmacy Groups tell HHS that Any Action on Rebate Rule Must Involve Fixing Pharmacy DIR Fees Jul 29, 2020 WASHINGTON, DC (July 29, 2020) – As we continue to navigate this unprecedented time of uncertainty,... read more
- NASP Submits Comments to CMS Jul 23, 2020 WASHINGTON, DC (July 23, 2020) – The National Association of Specialty Pharmacy (NASP) recently submitted comments... read more
- NASP submits comments to CMS on CMS-1744-IFC Jun 01, 2020 WASHINGTON, DC (June 1, 2020) – Please click here to read NASP’s comments submitted Monday, June... read more
- More than ¼ of the House of Representatives Call for Pharmacy DIR Reform Action Now Apr 27, 2020 WASHINGTON, DC (April 27, 2020) – With the help of the National Association of Specialty Pharmacy,... read more
- BiPartisan Support for DIR Reform in Next Congressional Stimulus Bill Apr 14, 2020 WASHINGTON, DC (April 14, 2020) – A bipartisan group of House Members of Congress is leading... read more
- NASP submits Comments to CMS on the 2021 and 2022 Proposed Rule Apr 07, 2020 WASHINGTON, DC (April 7, 2020) – Please click here to read NASP’s comments submitted Monday, April... read more
- Pharmacists Call for New Action to Enhance COVID-19 Patient Care Mar 20, 2020 WASHINGTON, DC (March 20, 2020) – NASP joined major pharmacy organizations, representing the interests of pharmacists... read more
- Pharmacy Reimbursement Modernization Needed, Report Says Mar 03, 2020 WASHINGTON, DC (March 3, 2020) – NACDS, NCPA and NASP: Patient access, fairness to pharmacies... read more
- Specialty Pharmacy Supports State Effort to Regulate PBM Practices Mar 03, 2020 For Immediate Release WASHINGTON, DC (March 3, 2020) – The National Association of Specialty Pharmacy (NASP)... read more
- Pharmacy Urges Decisive Action to Close DIR Fee Loophole, Appreciates Senate Finance Committee’s Initial Bipartisan Movement on Issue Jul 29, 2019 FOR IMMEDIATE RELEASE July 25, 2019 CONTACTS: Jack Mozloom, National Community Pharmacists Association Chris Krese, National... read more